Pediatric Oncology, Children's Hospital

Medicine & Life Sciences

1. Pediatrics 100%
2. Medulloblastoma 71%
3. Child 64%
4. Neuroblastoma 55%
5. Neoplasms 46%
6. Hematopoietic Stem Cell Transplantation 46%
7. Palliative Care 45%
8. Precursor Cell Lymphoblastic Leukemia-Lymphoma 41%
9. Bone Marrow Transplantation 32%
10. Protein C Deficiency 28%
11. Protein C 24%
12. Therapeutics 24%
13. Drug Therapy 23%
14. Transplants 22%
15. Anaplastic Large-Cell Lymphoma 20%
16. Trisomy 18 Syndrome 19%
17. temsirolimus 18%
18. MicroRNAs 18%
19. Hodgkin Disease 16%
20. Research Ethics Committees 16%
21. Trisomy 13 Syndrome 15%
22. Theranostic Nanomedicine 15%
23. Non-Hodgkin's Lymphoma 14%
24. Graft vs Host Disease 14%
25. Growth 13%
26. Whole-Body Irradiation 13%
27. Hedgehogs 12%
28. Multiple Organ Failure 12%
29. Etoposide 12%
30. Phosphatidylinositol 3-Kinases 12%
31. Lymphoma 12%
32. Proteins 12%
33. Immunotherapy 11%
34. Survival 11%
35. Central Nervous System 11%
36. Cell Line 11%
37. Bereavement 11%
38. Hemophagocytic Lymphohistiocytosis 10%
39. Communication 10%
40. Carbamates 10%
41. Antithrombin III 10%
42. Immunosuppression 9%
43. Cytarabine 9%
44. Recurrence 9%
45. Hospice Care 9%
46. Transplantation 8%
47. Untranslated RNA 8%
48. Proxy 8%
49. Mindfulness 8%
50. Cyclophosphamide 8%
51. Epigenomics 8%
52. Antithrombins 8%
53. Hematology 8%
54. Telemedicine 8%
55. Incidence 8%
56. Quality of Life 8%
57. Cell Cycle 8%
58. Homologous Transplantation 8%
59. Stem Cells 8%
60. Systematic Reviews 8%
61. Cisplatin 8%
62. In Vitro Techniques 8%
63. CBLC137 7%
64. Hematopoietic Stem Cells 7%
65. Nanoparticles 7%
66. Chromosome Aberrations 7%
67. HhAntag691 7%
68. Antithrombin Proteins 7%
69. Pharmaceutical Preparations 7%
70. Down Syndrome 7%
71. Advance Care Planning 7%
72. Electronic Health Records 7%
73. Fluorescence In Situ Hybridization 7%
74. Hemorrhage 7%
75. Bone Marrow 7%
76. Human Herpesvirus 4 7%
77. circulating anticoagulants 7%
78. Trisomy 18q Chromosome 18 7%
79. Fetal Blood 7%
80. Radiotherapy 7%
81. Leukemia 7%
82. Messenger RNA 6%
83. 1,2,4-trioxane 6%
84. Thiotepa 6%
85. Nurses 6%
86. Deoxyuridine 6%
87. Documentation 6%
88. Research Subjects 6%
89. Sinus Histiocytosis 6%
90. Natural Killer Cells 6%
91. Guanidines 6%
92. Hospices 6%
93. Acute Myeloid Leukemia 6%
94. Refusal to Treat 6%
95. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6%
96. Long Noncoding RNA 6%
97. Granulocyte-Macrophage Colony-Stimulating Factor 6%
98. Anaplastic Lymphoma Kinase 6%
99. Pediatricians 6%